Progress and challenges in CRISPR-mediated therapeutic genome editing for monogenic diseases

There are an estimated 10 000 monogenic diseases affecting tens of millions of individuals worldwide. The application of CRISPR/Cas genome editing tools to treat monogenic diseases is an emerging strategy with the potential to generate personalized treatment approaches for these patients. CRISPR/Cas...

Descripción completa

Detalles Bibliográficos
Autores principales: Konishi, Colin T., Long, Chengzu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Editorial Department of Journal of Biomedical Research 2021
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8038532/
https://www.ncbi.nlm.nih.gov/pubmed/33402545
http://dx.doi.org/10.7555/JBR.34.20200105

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8038532/
https://www.ncbi.nlm.nih.gov/pubmed/33402545
http://dx.doi.org/10.7555/JBR.34.20200105

Ejemplares similares